However, we noticed a higher prevalence of patients with elevated MCP-1 levels in the tested anti-gp210 positive group of PBC patients 36/39 (92%) than in anti-gp210 negative PBC patients 43/81 (53%), p < 0.0001. Here, CCL2 is linked to primary biliary cholangitis.